comprehensive -WSS

comprehensive

author：focus 2025-09-30 15:15:55 - browse：47

A new treatment for Alzheimer’s disease developed by Eli Lilly slowed patients’ rate of cognitive and functional decline by 35% compared to placebo, the company said Wednesday, paving the way for a submission to the Food and Drug Administration and boosting hopes for a new class of Alzheimer’s drugs.

But the positive outcome of the study involving the drug, called donanemab, could be tempered by the deaths of two patients, and possibly a third, from a type of brain swelling caused by these drugs.

The results of the study were reported in a press release and have not yet been reviewed by outside scientists. Lilly said the data will be used to file for full approval with the FDA before the end of June. If cleared, donanemab will compete with another new Alzheimer’s treatment, Leqembi, made by Eisai and Biogen, that secured FDA approval in January.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Following judge's order, DOJ releases slightly less

focus

WSS

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

American TikTok star stuck in Dubai for months following rental car altercation

EU moves toward latest gene techniques in food production to counter climate change, shortages

American TikTok star stuck in Dubai for months following rental car altercation

EU moves toward latest gene techniques in food production to counter climate change, shortages

Israel withdraws forces after 2

hotspot

comprehensive

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Dobbs anniversary: the lost opportunity of abortion as health care

HCA says smaller share of spending going to labor

Sports medicine is finally prioritizing gender equality

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Walensky prepares to leave CDC — and Congress — behind

Condition critical? Britain's beloved but battered National Health Service turns 75

Moonlake's readout produced a cash windfall. Risks remain

5 wounded, 2 critically, in Michigan shopping center shooting

leisure time

Following judge's order, DOJ releases slightly less

Poland's lawmakers approve a divisive law on Russian influence

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

Israel withdraws forces after 2

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Search warrant issued in 1996 disappearance of Kristin Smart

focus

leisure time

Wikipedia

focus